Recombinant Rabbit CCL5 Protein

• Cat.No.: CCL5-4353R
• Product Overview: Recombinant Rabbit CCL5 Protein (68aa) was expressed in yeast.

Specification

• Source: Yeast
• Species: Rabbit
• Form: Lyophilized
• Molecular Mass: 7.9 kDa
• Protein length: 68aa
• AA sequence: SPYASDTTPC CFAYISRLLP RAHVTEYFYT SGKCSFPAVV FVTRKNRQVC ANPEKKWVRE YINSLEMS (68)
• Purity: >95% as visualized by SDS-PAGE analysis.
• Applications: This endotoxin-free recombinant protein can be used in cell culture, ELISA Standard, and as a Western Blot Control.
• Storage: Store at -20 centigrade.
• Tag: Non

Gene Information

• Gene Name: CCL5 C-C motif chemokine ligand 5 [ Oryctolagus cuniculus (rabbit) ]
• Official Symbol: CCL5
• Synonyms: CCL5; C-C motif chemokine 5
• Gene ID: 100348266
• mRNA Refseq: XM_017349037.1
• Protein Refseq: XP_017204526.1

Reviews

08/17/2021

This specificity enables precise quantification and characterization of CCL5 and its interactions with other molecules or proteins of interest.

06/23/2019

Its exceptional performance, coupled with its ability to generate clear and precise protein bands, make it an indispensable tool in achieving accurate and reliable results.

06/20/2016

The CCL5 protein exhibits a high degree of specificity in various assays, ensuring accurate and reliable results.

Q&As

What are the potential clinical applications of CCL5 inhibitors?

CCL5 inhibitors may be used to control inflammation in diseases like rheumatoid arthritis or as an adjuvant in cancer therapy.

Can CCL5 be used to stimulate the immune system in cancer treatment?

CCL5-based immunotherapies are being explored to enhance the immune response against cancer cells.

Can CCL5 be used as a diagnostic marker for diseases?

It can serve as a biomarker for some diseases, but it is usually used in conjunction with other markers for more accurate diagnostics.

What are the clinical implications of elevated CCL5 levels?

Elevated CCL5 levels are associated with inflammation and may be indicative of certain diseases such as rheumatoid arthritis or HIV infection.

Are there any CCL5-targeted therapies in development?

Yes, there are ongoing efforts to develop therapies that modulate CCL5 activity, particularly in diseases involving inflammation.